PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Dmitry Kudlay: Russian Technologies Break Into the Global Stage But Stall in Public Procurement
Russian pharmaceutical science has reached a level where innovative...
PSK Pharma Challenges Pfizer’s Rheumatoid Arthritis Drug Patent in Court
Russian pharmaceutical company PSK Pharma has filed a lawsuit...
ST-1 Certificate Outweighs Active Substance: Court Forbids State Buyers from Reevaluating Drug Origin
The Arbitration Court of Moscow has issued a precedent-setting...
TSU Scientists Synthesize Pharmaceutical Raw Materials from Capron Production By-products
As part of the development of waste-free production and...
